{
    "root": "30ba1cee-116f-089d-e063-6394a90a426f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Cephalexin",
    "value": "20250319",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "CEPHALEXIN",
            "code": "OBN7UDS42Y",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3534"
        }
    ],
    "indications": {
        "text": "cephalexin capsules cephalosporin antibacterial indicated treatment following infections caused susceptible isolates designated bacteria : respiratory tract infection ( 1.1 ) otitis media ( 1.2 ) skin skin structure infections ( 1.3 ) bone infections ( 1.4 ) genitourinary tract infections ( 1.5 ) reduce development drug-resistant bacteria maintain effectiveness cephalexin capsules antibacterial drugs , cephalexin capsules used treat infections proven strongly suspected caused bacteria . ( 1.6 )",
        "doid_entities": [
            {
                "text": "otitis media (DOID:10754)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10754"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adults patients least 15 years age usual dose 250 mg every 6 hours , dose 500 mg every 12 hours may administered ( 2.1 ) pediatric patients ( 1 year age ) otitis media : 75 100 mg/kg equally divided doses every 6 hours ( 2.2 ) : 25 50 mg/kg given equally divided doses ( 2.2 ) severe infections : 50 100 mg/kg may administered equally divided doses ( 2.2 ) duration therapy ranges 7 14 days depending infection type severity . ( 2 ) adjustment required patients severe end stage renal disease ( esrd ) defined creatinine clearance 30 ml/min . ( 2.3 )",
        "doid_entities": [
            {
                "text": "otitis media (DOID:10754)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10754"
            },
            {
                "text": "end stage renal disease (DOID:783)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_783"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "250 mg capsule dark green opaque/white size \u201c 2 \u201d hard gelatin capsule filled white granular powder imprinted \u201c 42 \u201d dark green opaque cap \u201c 250 mg \u201d white body black ink . bottles 3 ndc 68071-3740-3 bottles 9 ndc 68071-3740-9",
    "adverseReactions": "cephalexin capsules contraindicated patients known hypersensitivity cephalexin members cephalosporin class antibacterial drugs .",
    "indications_original": "Cephalexin capsules are a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria: Respiratory tract infection ( 1.1 ) Otitis media ( 1.2 ) Skin and skin structure infections ( 1.3 ) Bone infections ( 1.4 ) Genitourinary tract infections ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules and other antibacterial drugs, cephalexin capsules should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. ( 1.6 )",
    "contraindications_original": "Adults and patients at least 15 years of age The usual dose is 250 mg every 6 hours, but a dose of 500 mg every 12 hours may be administered ( 2.1 ) Pediatric patients (over 1 year of age) Otitis media: 75 to 100 mg/kg in equally divided doses every 6 hours ( 2.2 ) All other indications: 25 to 50 mg/kg given in equally divided doses ( 2.2 ) In severe infections: 50 to 100 mg/kg may be administered in equally divided doses ( 2.2 ) Duration of therapy ranges from 7 to 14 days depending on the infection type and severity. ( 2 ) Dosage adjustment is required in patients with severe and end stage renal disease (ESRD) defined as creatinine clearance below 30 mL/min. ( 2.3 )",
    "warningsAndPrecautions_original": "250 mg Capsule\n                     \n                  \n                  Dark green opaque/white size \u201c2\u201d hard gelatin capsule filled with off white granular powder and imprinted with \u201cA 42\u201d on dark green opaque cap and \u201c250 mg\u201d on white body with black ink.\n                  Bottles of 3 NDC 68071-3740-3\n                  \n                  Bottles of 9 NDC 68071-3740-9",
    "adverseReactions_original": "Cephalexin capsules are contraindicated in patients with known hypersensitivity to cephalexin or other members of the cephalosporin class of antibacterial drugs.",
    "drug": [
        {
            "name": "Cephalexin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3534"
        }
    ]
}